Dan Dees
Showing 1–6 of 6 transcripts.
- Goldman Sachs22 min
AppLovin's Adam Foroughi: The Power of a Startup Mindset
AppLovin CEO Adam Farooqi leads the $200 billion mobile technology firm, which leverages a lean 400-person core team and advanced neural networks to dominate performance marketing and generate over $4 billion in annual EBITA. Following a near-total valuation collapse after its 2021 IPO, the company executed a strategic $5 billion share buyback program that restored over $100 billion in market value and drove stock prices to approximately $600 per share. Farooqi sustains this growth by enforcing a culture of extreme operational efficiency, mandatory AI integration for internal workflows, and direct personal oversight of all key hiring decisions.
- Goldman Sachs32 min
OpenAI CFO Sarah Friar on the race to build artificial general intelligence
Goldman Sachs and OpenAI leaders outline a strategic pivot toward full-stack infrastructure, highlighted by a $500 billion "Stargate" investment plan designed to secure 10 gigawatts of compute power for advanced reasoning models and autonomous agents. This capital deployment addresses severe hardware bottlenecks while driving breakthroughs in O-series models that now achieve PhD-level scientific proficiency and global coding supremacy. With revenue tripling annually and immediate plans to scale AI into education and enterprise banking, OpenAI aims to reach artificial general intelligence capabilities while treating an initial public offering as a long-term objective rather than an immediate priority.
- Goldman Sachs29 min
The pace of innovation in biotech: Mirador’s Mark McKenna
Former Prometheus Biosciences CEO Mark McKenna discusses the transformation of the biotech landscape from a pharma-dominated field to one driven by agile, high-risk companies like his current venture, Mirador Therapeutics, which recently secured $400 million in rapid fundraising. Drawing on his experience leading the $11 billion Merck acquisition of Prometheus, McKenna emphasizes that success now relies on leveraging generative AI for precision medicine, operating with a "speed as currency" philosophy to parallelize trials, and maintaining strategic secrecy to protect intellectual property against global competitors. The dialogue further outlines critical industry challenges, including the need to reform drug pricing models dominated by PBMs and to de-risk supply chains from over-reliance on Chinese manufacturing.
- Goldman Sachs30 min
Investment Banking - Goldman Sachs 2020 Investor Day
Greg Lemkaw, Dan Dees, John, David, Jim Esposito, Ashok Varadhan
Co-led by Greg Lemkau and Dan Dees, the investment bank reinforces its position as the global market leader in M&A and underwriting through a strategy targeting mid-cap growth, financial sponsors, and transaction banking. The firm leverages a vast network of over 10,000 clients and a culture of mentorship to drive record revenues, recently exemplified by landmark deals like the Spotify direct listing and the Fiat Chrysler-Peugeot merger. Looking toward 2025, leadership plans to expand coverage of $500M–$2B companies and launch a high-tech transaction banking platform to diversify revenue streams and achieve 1% global market share within five years.
- Goldman Sachs21 min
Vijay Shekhar Sharma: Founder and CEO of Paytm
Vijay Shekhar Sharma, Dan Dees, SAURABH MADAANI
Paytm founder Vijay Shekhar Sharma outlines his company's transformation from a cash-rich entity into India's largest private bank by pivoting to a mobile-first ecosystem that integrates financial and lifestyle services. This strategic evolution, supported by $300 million in foreign direct investment from Warren Buffett and guided by a corporate mantra of "no fear, no greed, no entitlement," positions the firm to compete globally rather than within national boundaries. Sharma emphasizes that lasting success requires entrepreneurs to pursue a purpose-driven mission over quick exits, using Paytm's own resilience against a failed 2010 IPO as a case study in overcoming uncertainty.
- Goldman Sachs23 min
Dikembe Mutombo: Empowering Athletes to Give Back
NBA legend Dikembe Mutombo, who directed 75% to 80% of his personal wealth toward the Dikembe Mutombo Foundation, has treated nearly 500,000 individuals in the Democratic Republic of Congo and is expanding his medical infrastructure through a new biochemistry high school and advanced cancer detection technology. Leveraging his background as a top-four draft pick who redefined the game's defensive standards, Mutombo advocates for four-year college education models over the "one-and-done" system while predicting NBA revenues will triple to $20 billion through expansion into Asian and African markets. His philanthropic strategy focuses on training local doctors to reduce foreign aid dependency and honoring his father's legacy, effectively shifting the league's cultural focus toward sustainable community investment.